5 Reasons SEC Regulation A+ is Revolutionary

Mitchell Silberberg and Knupp LLP |


For entrepreneurs, the recent changes to SEC Regulation A+ is a hugely exciting step forward. As it happens, blogger, lawyer and author of The Entrepreneur's Growth Startup Handbook David Feldman was actually a key figure in the development of the new guidelines. In this edition of The Entrepreneur's Advocate, Clara Chalk interviews Feldman about his involvement in Reg A+, and why the new rules are so revolutionary. Check out the interview below:

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

PixarBio Corp

PixarBio Corp is a specialty pharmaceutical/biotechnology company focused on pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

Santo Diablo Mezcal

Santo Diablo Mezcal has been created to capitalize on a boom sector of the beverage market currently full of many small unmemorable products by producing one sexy, household, easily recognizable…